Sanctura Approval History
FDA Approved: Yes (Discontinued) (First approved May 28, 2004)
Brand name: Sanctura
Generic name: trospium chloride
Dosage form: Tablets
Company: Allergan plc
Treatment for: Urinary Frequency, Urinary Incontinence
Marketing Status: Discontinued
Sanctura (trospium chloride) is an antispasmodic, antimuscarinic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Development History and FDA Approval Process for Sanctura
|Aug 6, 2007||Indevus Announces FDA Approval of Sanctura XR|
|May 28, 2004||Sanctura Indevus Pharmaceuticals, Inc. - Treatment for Overactive Bladder|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.